Cargando…
A “Double-Locked” and Enzyme/pH-Activated Theranostic Agent for Accurate Tumor Imaging and Therapy
Theranostic agents for concurrent cancer therapy and diagnosis have begun attracting attention as a promising modality. However, accurate imaging and identification remains a great challenge for theranostic agents. Here, we designed and synthesized a novel theranostic agent H6M based on the “double-...
Autores principales: | Luo, Jia, Guan, Zongyu, Gao, Weijie, Wang, Chen, Xu, Zhongyuan, Meng, Chi, Liu, Yun, Zhang, Yuquan, Guo, Qingsong, Ling, Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8779152/ https://www.ncbi.nlm.nih.gov/pubmed/35056740 http://dx.doi.org/10.3390/molecules27020425 |
Ejemplares similares
-
MMP-13 enzyme and pH responsive theranostic nanoplatform for osteoarthritis
por: Lan, Qiumei, et al.
Publicado: (2020) -
Recent Advances in Imaging Agents Anchored with pH (Low) Insertion Peptides for Cancer Theranostics
por: Liu, Yu-Cheng, et al.
Publicado: (2023) -
A “Double-Locked” and enzyme-activated molecular probe for accurate bioimaging and hepatopathy differentiation
por: Liu, Yongchao, et al.
Publicado: (2019) -
pH-responsive theranostic nanocomposites as synergistically enhancing positive and negative magnetic resonance imaging contrast agents
por: Huang, Xi, et al.
Publicado: (2018) -
A new pH/NIR responsive theranostic agent for magnetic resonance imaging guided synergistic therapy
por: Du, Yechao, et al.
Publicado: (2021)